Viewing nowCombinationLinaDiPo Duo Sustained Release Tablet 5/1000 mg (Linagliptin, Metformin)
Metformin Hydrochloride 1000mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.

MFDS item code 202400567 · Approved 2024.03.18 · Insurance code 670609330
Improvement of blood glucose control in patients with type 2 diabetes mellitus
This medication is prescribed to assist with blood glucose control in patients with type 2 diabetes. Particularly, when used in combination with linagliptin and metformin, along with dietary control and exercise therapy, it is effective for blood sugar management. This helps maintain stable blood glucose levels and can assist in the prevention of diabetes-related complications. When used consistently along with lifestyle management, it contributes to maintaining a healthy life. This medicine improves blood glucose control in type 2 diabetes.
For antidiabetic therapy, the dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: linagliptin 5mg and metformin hydrochloride (extended-release) 2000 mg. Take this medicine once daily with a meal, preferably with the evening meal. To reduce gastrointestinal adverse reactions associated with metformin use, the dose of metformin hydrochloride should be increased gradually. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it. Take one 5/1000 mg extended-release tablet once daily. Patients taking the 2.5/1000 mg extended-release tablet should take two tablets at the same time once daily. 1. Patients not currently receiving metformin: The initial total daily dose of this medicine is linagliptin 5 mg and metformin hydrochloride 1000mg. The dose of metformin hydrochloride may be gradually increased up to the maximum recommended daily dose of 2000 mg. 2. Patients receiving metformin - For patients who cannot achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine is a total daily dose of linagliptin 5 mg and the patient's current dose of metformin hydrochloride. - For patients who cannot achieve adequate glycemic control with metformin plus a sulfonylurea or metformin plus insulin, the initial dose of this medicine should be considered as a total daily dose of linagliptin 5mg and a dose of metformin hydrochloride similar to the patient's current dose. When this medicine is administered in combination with insulin or a sulfonylurea, a reduction in the dose of insulin or the sulfonylurea may be necessary to reduce the risk of hypoglycemia. - When switching from an immediate-release metformin formulation to an extended-release formulation, glycemic control should be closely monitored and the dose adjusted appropriately if necessary. - When switching from combination therapy with linagliptin and extended-release metformin to this medicine, the dose of this medicine is the patient's current dose of linagliptin and extended-release metformin hydrochloride. Renal impairment Because dosage adjustment based on renal function is necessary, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. No dosage adjustment is necessary in patients with mild renal impairment [creatinine clearance (CrCl) ≧ 60mL/min or estimated glomerular filtration rate (eGFR) ≧ 60mL/min/1.73 m2]. In patients with moderate renal impairment (CKD stage 3A), with creatinine clearance (CrCl) ≥ 45mL/min and < 60mL/min or estimated glomerular filtration rate (eGFR) ≥ 45mL/min/1.73m2 and < 60mL/min/1.73m2, this medicine may be used with metformin hydrochloride dose adjustment as follows, provided it is well tolerated and the patient has no other condition that may increase the risk of lactic acidosis. The starting dose of metformin hydrochloride is 500mg or 750mg once daily; therefore, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000mg. If creatinine clearance (CrCl) decreases to < 45mL/min or estimated glomerular filtration rate (eGFR) decreases to < 45mL/min/1.73m2, discontinue this medicine immediately.
This medicine helps to control blood sugar levels, and its main ingredients include linagliptin and metformin. This medication can rarely cause a serious condition called lactic acidosis, which can be dangerous due to excessive accumulation of lactic acid in the body, so caution is required. Especially in patients with severely reduced kidney function, severe liver dysfunction, acute infections or trauma, shock states, or acute myocardial infarction, this medication should not be used. Additionally, individuals allergic to the components of this medication, patients with type 1 diabetes, diabetic ketoacidosis, or acute alcohol intoxication should not use this medication. This medication can lead to hypoglycemia, so especially when used alongside sulfonylureas or insulin, careful monitoring of blood glucose changes is necessary, and dosage adjustments may be required. To reduce the risk of lactic acidosis, if dehydration, severe vomiting or diarrhea, or situations of rapidly worsening kidney function occur, you should immediately stop taking this medication and consult a doctor. During treatment, it is important to regularly monitor kidney function to ensure the medication is safely excreted. This medication should be temporarily discontinued when undergoing surgery or radiation tests involving iodine contrast agents and should be resumed only after kidney function has recovered. While taking this medication, side effects such as acute pancreatitis or blistering similar to pemphigus may occur, and if these symptoms arise, you should inform your doctor immediately. Long-term use may lead to vitamin B12 deficiency, so regular blood testing may be necessary. This medication should be swallowed whole without chewing, breaking, crushing, or splitting, and it is normal for the tablet coating to be excreted in the stool. It is advisable for pregnant or breastfeeding women not to use this medication, and especially if planning pregnancy, to consult a physician for safe treatment options. Elderly patients commonly experience reduced kidney function, so it is recommended to frequently check kidney function and treat with the minimum effective dose. There is no research on the effects of this medication on driving or operating machinery, but caution is needed as symptoms of hypoglycemia may occur. In case of overdose, the medication may not be properly absorbed in the gastrointestinal tract, and serious side effects such as lactic acidosis may occur; prompt medical treatment is necessary. Finally, this medication should be stored out of reach of children, in a dry place, and not transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering, and the storage temperature should be maintained between 1 and 30 degrees Celsius. This way, the medication's efficacy can be safely preserved.
Pink, oval-shaped, bilaterally convex, sustained release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 1000mg · Linagliptin Micronized 5mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Linagliptin Micronized 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
Linagliptin Micronized 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
Linagliptin Micronized 2.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationLinagliptin Micronized 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationLinagliptin Micronized 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationLinagliptin Micronized 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationLinagliptin Micronized 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.